{"altmetric_id":9658478,"counts":{"readers":{"mendeley":18,"citeulike":0,"connotea":0},"total":{"posts_count":10},"twitter":{"unique_users_count":5,"unique_users":["epigen_papers","asociacion_php","guionanclares","Bealecum","CurroNeuro"],"posts_count":8},"facebook":{"unique_users_count":1,"unique_users":["169299486576410"],"posts_count":2}},"selected_quotes":["A transdisciplinary and multicentric collaborative effort. A proposal for a step forward. Honored to be in this team","Pubmed: From Pseudohypoparathyroidism to inactivating PTH\/PTHrP Signalling Disorder (iPPSD), a novel classification\u2026 htt\u2026","A clinical diagnosis with molecular subtypes: from surface to inside.","Pubmed: From Pseudohypoparathyroidism to inactivating PTH\/PTHrP Signalling Disorder (iPPSD), a novel classification\u2026"],"citation":{"abstract":"Disorders caused by impairments in the parathyroid hormone (PTH) signalling pathway are historically classified under the term pseudohypoparathyroidism (PHP), that encompasses rare, related but highly heterogeneous diseases with demonstrated (epi)genetic causes. The actual classification is based on the presence or absence of specific clinical and biochemical signs together with an in vivo response to exogenous PTH and the results of an in vitro assay to measure Gsa protein activity. However, this classification disregards other related diseases like acrodysostosis (ACRDYS) or Progressive Osseous Heteroplasia (POH), as well as recent findings of clinical and genetic\/epigenetic background of the different subtypes. Therefore, the EuroPHP network decided to develop a new classification that encompasses all disorders with impairments in PTH and\/or PTHrP cAMP-mediated pathway.\nExtensive review of the literature was performed. Several meetings were organised to discuss about a new, more effective and accurate way to describe disorders caused by abnormalities of the PTH\/PTHrP signalling pathway.\nAfter determining the major and minor criteria to be considered for the diagnosis of these disorders, we proposed to group them under the term \u00abinactivating PTH\/PTHrP signalling disorder\u00bb, (iPPSD). This terminology: 1) defines the common mechanism responsible for all diseases, 2) does not require a confirmed genetic defect, 3) avoids ambiguous terms like \"pseudo\", 4) eliminates the clinical or molecular overlap between diseases. We believe that the use of this nomenclature and classification will facilitate the development of rationale and comprehensive international guidelines for the diagnosis and treatment of iPPSDs.","altmetric_jid":"4f6fa4eb3cf058f610002832","authors":["Thiele, Susanne","Mantovani, Giovanna","Barlier, Anne","Boldrin, Valentina","Bordogna, Paolo","de Sanctis, Luisa","Elli, Francesca","Freson, Kathleen","Garin, Intza","Grybek, Virginie","Hanna, Patrick","Izzi, Benedetta","Hiort, Olaf","Lecumberri, Beatriz","Pereda, Arrate","Saraff, Vrinda","Silve, Caroline","Turan, Serap","Usardi, Alessia","Werner, Ralf","Perez de Nanclares, Guiomar","Linglart, Agn\u00e8s","Susanne  Thiele","Giovanna  Mantovani","Anne  Barlier","Valentina  Boldrin","Paolo  Bordogna","Luisa  de Sanctis","Francesca  Elli","Kathleen  Freson","Intza  Garin","Virginie  Grybek","Patrick  Hanna","Benedetta  Izzi","Olaf  Hiort","Beatriz  Lecumberri","Arrate  Pereda","Vrinda  Saraff","Caroline  Silve","Serap  Turan","Alessia  Usardi","Ralf  Werner","Guiomar  Perez de Nanclares","Agn\u00e8s  Linglart","Susanne Thiele","Giovanna Mantovani","Anne Barlier","Valentina Boldrin","Paolo Bordogna","Luisa De Sanctis","Francesca M Elli","Kathleen Freson","Intza Garin","Virginie Grybek","Patrick Hanna","Benedetta Izzi","Olaf Hiort","Beatriz Lecumberri","Arrate Pereda","Vrinda Saraff","Caroline Silve","Serap Turan","Alessia Usardi","Ralf Werner","Guiomar Perez de Nanclares","Agn\u00e8s Linglart"],"doi":"10.1530\/eje-16-0107","first_seen_on":"2016-07-13T16:17:12+00:00","funders":["niehs"],"issns":["1479-683X","0804-4643"],"journal":"European Journal of Endocrinology","last_mentioned_on":1491234167,"links":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27401862?dopt=Abstract&utm_source=dlvr.it&utm_medium=twitter","http:\/\/www.eje-online.org\/content\/early\/2016\/07\/11\/EJE-16-0107.full.pdf","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27401862","https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27401862?dopt=Abstract&utm_source=dlvr.it&utm_medium=twitter"],"pdf_url":"http:\/\/www.eje-online.org\/content\/early\/2016\/07\/11\/EJE-16-0107.full.pdf","pmid":"27401862","pubdate":"2016-07-11T00:00:00+00:00","publisher_subjects":[{"name":"Clinical Sciences","scheme":"era"},{"name":"Paediatrics And Reproductive Medicine","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Biochemistry, Genetics and Molecular Biology"],"startpage":"EJE-16-0107","subjects":["endocrinology"],"title":"From Pseudohypoparathyroidism to inactivating PTH\/PTHrP Signalling Disorder (iPPSD), a novel classification proposed by the European EuroPHP network","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/pseudohypoparathyroidism-inactivating-pthpthrp-signalling-disorder-ippsd-novel-classification-propos"},"altmetric_score":{"score":4.2,"score_history":{"1y":0.85,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":4.2},"context_for_score":{"all":{"total_number_of_other_articles":8454083,"mean":7.1051250224367,"rank":1838438,"this_scored_higher_than_pct":78,"this_scored_higher_than":6604435,"rank_type":"exact","sample_size":8454083,"percentile":78},"similar_age_3m":{"total_number_of_other_articles":261917,"mean":11.788497304479,"rank":71901,"this_scored_higher_than_pct":72,"this_scored_higher_than":189448,"rank_type":"exact","sample_size":261917,"percentile":72},"this_journal":{"total_number_of_other_articles":1542,"mean":4.36331862427,"rank":242,"this_scored_higher_than_pct":84,"this_scored_higher_than":1299,"rank_type":"exact","sample_size":1542,"percentile":84},"similar_age_this_journal_3m":{"total_number_of_other_articles":46,"mean":6.8455555555556,"rank":9,"this_scored_higher_than_pct":80,"this_scored_higher_than":37,"rank_type":"exact","sample_size":46,"percentile":80}}},"demographics":{"poster_types":{"member_of_the_public":4,"practitioner":1},"users":{"twitter":{"cohorts":{"Members of the public":4,"Practitioners (doctors, other healthcare professionals)":1}},"mendeley":{"by_status":{"Professor > Associate Professor":1,"Researcher":7,"Student  > Ph. D. Student":3,"Student  > Postgraduate":2,"Other":3,"Student  > Bachelor":1,"Professor":1},"by_discipline":{"Medicine and Dentistry":13,"Agricultural and Biological Sciences":3,"Biochemistry, Genetics and Molecular Biology":2}}},"geo":{"twitter":{"FR":1,"ES":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/epigen_papers\/statuses\/753243623106359300","license":"gnip","citation_ids":[9658478],"posted_on":"2016-07-13T15:04:08+00:00","author":{"name":"epigenetics_papers","url":"http:\/\/en.wikipedia.org\/wiki\/Epigenetics","image":"https:\/\/pbs.twimg.com\/profile_images\/471205704921931776\/wSQqKYz8_normal.jpeg","description":"Chromatin & epigenetics paper feed from #Pubmed and #Arxiv - hear it here first! Comments & suggestions welcome. Also http:\/\/t.co\/0Lque7l3ZD By @mariamdemidova","id_on_source":"epigen_papers","tweeter_id":"2526900595","geo":{"lt":48.11198,"ln":-1.67429,"country":"FR"},"followers":1926},"tweet_id":"753243623106359300"},{"url":"http:\/\/twitter.com\/asociacion_php\/statuses\/755453163977711616","license":"gnip","citation_ids":[9658478],"posted_on":"2016-07-19T17:24:04+00:00","author":{"name":"Asociacion PHP","image":"https:\/\/pbs.twimg.com\/profile_images\/618205682337251328\/xu6idVp3_normal.jpg","description":"Asociaci\u00f3n Espa\u00f1ola de Pseudohipoparatiroidismo","id_on_source":"asociacion_php","tweeter_id":"3291809470","geo":{"lt":null,"ln":null},"followers":70},"tweet_id":"755453163977711616"},{"url":"http:\/\/twitter.com\/asociacion_php\/statuses\/755453798571802624","license":"gnip","citation_ids":[9658478],"posted_on":"2016-07-19T17:26:35+00:00","author":{"name":"Asociacion PHP","image":"https:\/\/pbs.twimg.com\/profile_images\/618205682337251328\/xu6idVp3_normal.jpg","description":"Asociaci\u00f3n Espa\u00f1ola de Pseudohipoparatiroidismo","id_on_source":"asociacion_php","tweeter_id":"3291809470","geo":{"lt":null,"ln":null},"followers":70},"tweet_id":"755453798571802624"},{"url":"http:\/\/twitter.com\/guionanclares\/statuses\/755457828379295745","license":"gnip","rt":["asociacion_php"],"citation_ids":[9658478],"posted_on":"2016-07-19T17:42:36+00:00","author":{"name":"GUIOMAR","image":"https:\/\/pbs.twimg.com\/profile_images\/598501193795674112\/viFTITps_normal.jpg","id_on_source":"guionanclares","tweeter_id":"3251720069","geo":{"lt":null,"ln":null},"followers":100},"tweet_id":"755457828379295745"},{"url":"http:\/\/twitter.com\/guionanclares\/statuses\/755457836625297408","license":"gnip","rt":["asociacion_php"],"citation_ids":[9658478],"posted_on":"2016-07-19T17:42:38+00:00","author":{"name":"GUIOMAR","image":"https:\/\/pbs.twimg.com\/profile_images\/598501193795674112\/viFTITps_normal.jpg","id_on_source":"guionanclares","tweeter_id":"3251720069","geo":{"lt":null,"ln":null},"followers":100},"tweet_id":"755457836625297408"},{"url":"http:\/\/twitter.com\/Bealecum\/statuses\/755480846493188096","license":"gnip","citation_ids":[9658478],"posted_on":"2016-07-19T19:14:04+00:00","author":{"name":"Beatriz","image":"https:\/\/pbs.twimg.com\/profile_images\/704331445486100481\/0s3RvFIf_normal.jpg","description":"MD, PhD","id_on_source":"Bealecum","tweeter_id":"3763187235","geo":{"lt":null,"ln":null},"followers":60},"tweet_id":"755480846493188096"},{"url":"http:\/\/twitter.com\/CurroNeuro\/statuses\/755610738278993920","license":"gnip","rt":["Bealecum"],"citation_ids":[9658478],"posted_on":"2016-07-20T03:50:13+00:00","author":{"name":"Fco J Rguez Rivera","url":"https:\/\/www.facebook.com\/Rodr%C3%ADguez-de-Rivera-727322224056230\/","image":"https:\/\/pbs.twimg.com\/profile_images\/681459171447955457\/wITHSaGy_normal.jpg","description":"Neurologo. Coordinador de Enfermedades Neuromusculares y CSUR de Ataxias. Hospital Universitario La Paz- Hptal. Carlos III. Madrid. Espa\u00f1a.","id_on_source":"CurroNeuro","tweeter_id":"161570493","geo":{"lt":40.42526,"ln":-3.69063,"country":"ES"},"followers":1213},"tweet_id":"755610738278993920"},{"url":"http:\/\/twitter.com\/Bealecum\/statuses\/848923742050951169","license":"gnip","rt":["epigen_papers"],"citation_ids":[9658478],"posted_on":"2017-04-03T15:42:47+00:00","author":{"name":"Beatriz","image":"https:\/\/pbs.twimg.com\/profile_images\/704331445486100481\/0s3RvFIf_normal.jpg","description":"MD, PhD","id_on_source":"Bealecum","tweeter_id":"3763187235","geo":{"lt":null,"ln":null},"followers":60},"tweet_id":"848923742050951169"}],"facebook":[{"title":"http:\/\/www.eje-online.org\/content\/early\/2016\/07\/11\/EJE-16-0107.full.pdf","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=598693460303675&id=169299486576410","license":"public","citation_ids":[9658478],"posted_on":"2016-07-19T17:26:32+00:00","summary":"Even both @AgnesLinglart and @guionanclares told us the proposal of a new nomenclature for #pseudohypoparathyroidism and related disorder, the article they published within the #EuroPHP is already available","author":{"name":"PHP Pseudohipoparatiroidismo Ia-b","url":"https:\/\/www.facebook.com\/169299486576410","facebook_wall_name":"PHP Pseudohipoparatiroidismo Ia-b","image":"https:\/\/graph.facebook.com\/169299486576410\/picture","id_on_source":"169299486576410"}},{"title":"http:\/\/www.eje-online.org\/content\/early\/2016\/07\/11\/EJE-16-0107.full.pdf","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=598692936970394&id=169299486576410","license":"public","citation_ids":[9658478],"posted_on":"2016-07-19T17:24:01+00:00","summary":"Aunque tanto @AgnesLinglart como @guionanclares nos lo comentaron en primicia en la reuni\u00f3n del pasado mes en Madrid, ya ha sido publicado el art\u00edculo que propone una nueva nomenclatura en la que incluir no s\u00f3lo el #pseudohipoparatiroidismo en cada una de","author":{"name":"PHP Pseudohipoparatiroidismo Ia-b","url":"https:\/\/www.facebook.com\/169299486576410","facebook_wall_name":"PHP Pseudohipoparatiroidismo Ia-b","image":"https:\/\/graph.facebook.com\/169299486576410\/picture","id_on_source":"169299486576410"}}]}}